Sandoz Inc. 506 Carnegie Center Drive, Suite 400 Princeton, NJ 08540 Phone +1 609 627 8500 Fax +1 609 627 8682
Sandoz launches generic version of Sarafem® capsules
Princeton, New Jersey; November 25, 2008 -- Sandoz today announced the introduction of fluoxetine hydrochloride capsules, a generic equivalent of Sarafem® capsules, in the United States. Fluoxetine hydrochloride is an oral serotonin reuptake inhibitor used to treat mood changes and physical symptoms, including breast tenderness, headache, bloating and joint pain, associated with premenstrual dysphoric disorder (PMDD). As many as 10 percent of menstruating women suffer from PMDD. Sandoz is marketing fluoxetine hydrochloride in 10 and 20 mg strengths in unit of use blister packages of 28 capsules (4 x 7). About Sandoz Sandoz, a Division of the Novartis group, is a global leader in the field of generic pharmaceuticals, offering a wide array of high-quality, affordable products that are no longer protected by patents. Sandoz has a portfolio of more than 950 compounds and sells its products in more than 130 countries. Key product groups include antibiotics, treatments for central nervous system disorders, gastrointestinal medicines, cardiovascular treatments and hormone therapies. Sandoz develops, produces and markets these medicines along with pharmaceutical and biotechnological active substances and anti-infectives. In addition to strong organic growth in recent years, Sandoz has made a series of acquisitions including Lek (Slovenia), Sabex (Canada), Hexal (Germany) and Eon Labs (US) In 2007, Sandoz employed around 23,000 people worldwide and posted sales of USD 7.2 billion Disclaimer The foregoing release contains forward-looking statements that can be identified by terminology such as "may", "could", "likely", "suggests", "will", "risk", "confidence", or similar expressions, or by express or implied discussions regarding potential future revenues from fluoxetine hydrochloride capsules. Such forward-looking statements reflect the current views of the Company regarding future events, and involve known and unknown risks, uncertainties and other factors that may cause actual results with fluoxetine hydrochloride capsules to be materially different from any future results, performance or achievements expressed or implied by such statements. There can be no guarantee that fluoxetine hydrochloride capsules will receive any additional marketing approvals in any other countries or achieve any particular levels of revenue in the future. In particular, management's expectations regarding fluoxetine hydrochloride capsules could be affected by, among other things, competition and other risks and factors
referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Sandoz is providing the information in this press release as of this date and does not undertake any obligation to update any such forward-looking statements as a result of new information, future events or otherwise.
For further information Sandoz US Communications: Charles A. Bruns 609.627.8881 Sarafem ® is a registered trademark of Eli Lilly and Company. Page 2 of 2
Research summary* Anglo-Saxon vs. European capitalism Drifting apart, US and EU politicians follow underlying economic trends Politically, the European Union and the United States are drifting apart. But as we all know - since Karl Marx or Bill Clinton, depending on our age - economy always comes first. Actually, the economic cultures of the 'old' and the 'new' world were already moving
“Medical Wellness & Life Balance”Client Name: _____________________________________________ Date: ____________I am on the following medication: Birth Control_______________ Is there a Chance you are pregnant?_____ If on CARBATROL, TRILEPTAL, or DEPAKOTE and female, what birth control method do you use?_________________________________________________________________________________